Joint Venture (Tetra Bio-Pharma and Altus Formulation) Overview

  • Status
  • Private

  • Latest Deal Type
  • Joint Venture

  • Financing Rounds
  • 1

Joint Venture (Tetra Bio-Pharma and Altus Formulation) General Information

Description

Developer of a series of cannabinoid-receptor targeted therapeutics addressing multiple areas of high unmet need.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Corporate Backed or Acquired
Corporate Office
  • 365 rue Saint Jean
  • Suite 122
  • Longueuil, Quebec J4H 2X7
  • Canada
Primary Industry
Drug Delivery
Other Industries
Drug Discovery
Vertical(s)
Corporate Office
  • 365 rue Saint Jean
  • Suite 122
  • Longueuil, Quebec J4H 2X7
  • Canada

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Joint Venture (Tetra Bio-Pharma and Altus Formulation) Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Joint Venture (Tetra Bio-Pharma and Altus Formulation)‘s full profile, request access.

Request a free trial

Joint Venture (Tetra Bio-Pharma and Altus Formulation) Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Joint Venture (Tetra Bio-Pharma and Altus Formulation)‘s full profile, request access.

Request a free trial

Joint Venture (Tetra Bio-Pharma and Altus Formulation) FAQs

  • Where is Joint Venture (Tetra Bio-Pharma and Altus Formulation) headquartered?

    Joint Venture (Tetra Bio-Pharma and Altus Formulation) is headquartered in Longueuil, Canada.

  • What industry is Joint Venture (Tetra Bio-Pharma and Altus Formulation) in?

    Joint Venture (Tetra Bio-Pharma and Altus Formulation)’s primary industry is Drug Delivery.

  • Is Joint Venture (Tetra Bio-Pharma and Altus Formulation) a private or public company?

    Joint Venture (Tetra Bio-Pharma and Altus Formulation) is a Private company.

  • What is Joint Venture (Tetra Bio-Pharma and Altus Formulation)’s current revenue?

    The current revenue for Joint Venture (Tetra Bio-Pharma and Altus Formulation) is .

  • Who are Joint Venture (Tetra Bio-Pharma and Altus Formulation)’s investors?

    Altus Formulation (Other Pharmaceuticals and Biotechnology) and Tetra Bio-Pharma have invested in Joint Venture (Tetra Bio-Pharma and Altus Formulation).

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process